全文获取类型
收费全文 | 1111932篇 |
免费 | 76867篇 |
国内免费 | 1417篇 |
专业分类
耳鼻咽喉 | 15551篇 |
儿科学 | 35632篇 |
妇产科学 | 29742篇 |
基础医学 | 158978篇 |
口腔科学 | 30569篇 |
临床医学 | 99825篇 |
内科学 | 210220篇 |
皮肤病学 | 24897篇 |
神经病学 | 84566篇 |
特种医学 | 44602篇 |
外国民族医学 | 202篇 |
外科学 | 168225篇 |
综合类 | 22440篇 |
现状与发展 | 1篇 |
一般理论 | 284篇 |
预防医学 | 78999篇 |
眼科学 | 25400篇 |
药学 | 89028篇 |
9篇 | |
中国医学 | 2839篇 |
肿瘤学 | 68207篇 |
出版年
2019年 | 8303篇 |
2018年 | 11928篇 |
2017年 | 9436篇 |
2016年 | 10622篇 |
2015年 | 11860篇 |
2014年 | 16069篇 |
2013年 | 23475篇 |
2012年 | 32395篇 |
2011年 | 34172篇 |
2010年 | 19973篇 |
2009年 | 18684篇 |
2008年 | 31539篇 |
2007年 | 33776篇 |
2006年 | 34434篇 |
2005年 | 32758篇 |
2004年 | 31282篇 |
2003年 | 29979篇 |
2002年 | 29027篇 |
2001年 | 61203篇 |
2000年 | 62729篇 |
1999年 | 52027篇 |
1998年 | 12967篇 |
1997年 | 11421篇 |
1996年 | 11427篇 |
1995年 | 10751篇 |
1994年 | 9699篇 |
1993年 | 9223篇 |
1992年 | 38759篇 |
1991年 | 37174篇 |
1990年 | 36678篇 |
1989年 | 35148篇 |
1988年 | 31657篇 |
1987年 | 30751篇 |
1986年 | 28952篇 |
1985年 | 27182篇 |
1984年 | 19756篇 |
1983年 | 16622篇 |
1982年 | 9180篇 |
1979年 | 17562篇 |
1978年 | 11857篇 |
1977年 | 10564篇 |
1976年 | 9177篇 |
1975年 | 10383篇 |
1974年 | 12042篇 |
1973年 | 11660篇 |
1972年 | 11155篇 |
1971年 | 10469篇 |
1970年 | 9581篇 |
1969年 | 9205篇 |
1968年 | 8143篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
171.
172.
Hend Kothayer Samy M. Ibrahim Moustafa K. Soltan Samar Rezq Shireen S. Mahmoud 《Drug development research》2019,80(3):343-352
In light of the pharmacophoric structural requirements for achieving anticonvulsant activity, a series of N-(1-methyl-4-oxo-2-un/substituted-1,2-dihydroquinazolin-3[4H]-yl)benzamide (4a-g) and N-(1-methyl-4-oxo-2-un/substituted-1,2-dihydroquinazolin-3[4H]-yl)-2-phenylacetamide (4h-n) derivatives were synthesized in two steps starting from the reaction of N-methyl isatoic anhydride with the appropriate hydrazide and followed by condensation with the appropriate aldehyde. The anticonvulsant activities of the synthesized compounds were evaluated according to the anticonvulsant drug development (ADD) programme protocol. Among the synthesized compounds, 4n showed promising activity in both the maximal electroshock (MES) and pentylenetetrazole (PTZ) tests with median effective dose (ED50) values of 40.7 and 6 mg/kg, respectively. The six most promising derivatives, 4b , 4a , 4c , 4f , 4j , and 4i , showed very low ED50 values in the PTZ test (3.1, 4.96, 8.68, 9.89, 12, and 13.53 mg/kg, respectively). All the tested compounds showed no to low neurotoxicity in the rotarod test with a wide therapeutic index. Docking studies of compound 4n suggested that GABAA binding could be the mechanism of action of these derivatives. The in silico drug likeliness parameters indicated that none of the designed compounds violate Lipinski's rule of five and that they are able to cross the blood–brain barrier.
相似文献
Hit, Lead & Candidate Discovery |
173.
Heidi J Kalkwarf John A Shepherd Didier Hans Elena Gonzalez Rodriguez Joseph M Kindler Joan M Lappe Sharon Oberfield Karen K Winer Babette S Zemel 《Journal of bone and mineral research》2022,37(4):776-785
Trabecular bone score (TBS) is used for fracture prediction in adults, but its utility in children is limited by absence of appropriate reference values. We aimed to develop reference ranges for TBS by age, sex, and population ancestry for youth ages 5 to 20 years. We also investigated the association between height, body mass index (BMI), and TBS, agreement between TBS and lumbar spine areal bone mineral density (aBMD) and bone mineral apparent density (BMAD) Z-scores, tracking of TBS Z-scores over time, and precision of TBS measurements. We performed secondary analysis of spine dual-energy X-ray absorptiometry (DXA) scans from the Bone Mineral Density in Childhood Study (BMDCS), a mixed longitudinal cohort of healthy children (n = 2014) evaluated at five US centers. TBS was derived using a dedicated TBS algorithm accounting for tissue thickness rather than BMI. TBS increased only during ages corresponding to pubertal development with an earlier increase in females than males. There were no differences in TBS between African Americans and non-African Americans. We provide sex-specific TBS reference ranges and LMS values for calculation of TBS Z-scores by age and means and SD for calculation of Z-scores by pubertal stage. TBS Z-scores were positively associated with height Z-scores at some ages. TBS Z-scores explained only 27% and 17% of the variance of spine aBMD and BMAD Z-scores. Tracking of TBS Z-scores over 6 years was lower (r = 0.47) than for aBMD or BMAD Z-scores (r = 0.74 to 0.79), and precision error of TBS (2.87%) was greater than for aBMD (0.85%) and BMAD (1.22%). In sum, TBS Z-scores provide information distinct from spine aBMD and BMAD Z-scores. Our robust reference ranges for TBS in a well-characterized pediatric cohort and precision error estimates provide essential tools for clinical assessment using TBS and determination of its value in predicting bone fragility in childhood and adolescence. © 2022 American Society for Bone and Mineral Research (ASBMR). 相似文献
174.
Jennifer Wang Jonathan G. Stine Scott L. Cornella Curtis K. Argo Steven M. Cohn 《临床与转化肝病杂志(英文版)》2015,3(4):254-259
Background and Aims: Gastric antral vascular ectasia (GAVE) is commonly found in patients with cirrhosis, but it is also associated with other diseases in the absence of cirrhosis. Whether GAVE confers a different severity of gastrointestinal (GI) bleeding between patients with and without cirrhosis remains unknown. We aim to examine whether there is a difference in clinically significant GI bleeding due to GAVE in patients with or without cirrhosis. Methods: This is a retrospective case-control study of patients who were diagnosed with GAVE between January 2000 and June 2014. Patients were categorized into cirrhosis and noncirrhosis groups, and those with an additional GI bleeding source were excluded. Univariate comparisons and multivariable models were constructed using logistic regression. Results: In total, 110 patients diagnosed with GAVE on esophagogastroduodenoscopy (EGD) were included in our analysis; 84 patients had cirrhosis (76.4%) and 26 (23.6%) did not. Active GI bleeding was more prevalent in patients without cirrhosis (63.4% vs. 32.1%, p=0.003) despite similar indications for EGD, and endoscopic treatment with argon plasma coagulation (APC) was required more often in this group, approaching statistical significance (27% vs. 10.7%, p=0.056). There was no difference in bleeding severity, as evidenced by similar re-bleeding rates, surgery, or death attributed to uncontrolled bleeding. The strongest independent risk factor for GI bleeding was the absence of cirrhosis (odds ratio (OR): 5.151 (95% confidence interval (CI): 1.08-24.48, p=0.039). Conclusions: Patients with GAVE in the absence of cirrhosis are at higher risk for active GI bleeding and require more frequent endoscopic treatment than similar patients with cirrhosis. It may be worthwhile to treat GAVE in this population even in the absence of active bleeding. 相似文献
175.
176.
177.
178.
Interaction effects between the 5‐hydroxy tryptamine transporter‐linked polymorphic region (5‐HTTLPR) genotype and family conflict on adolescent alcohol use and misuse
下载免费PDF全文
![点击此处可从《Addiction (Abingdon, England)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
179.
Louise A. Rollins-Smith J. Scott Fites Laura K. Reinert Andrea R. Shiakolas Thomas P. Umile Kevin P. C. Minbiole 《Infection and immunity》2015,83(12):4565-4570
Batrachochytrium dendrobatidis is a fungal pathogen in the phylum Chytridiomycota that causes the skin disease chytridiomycosis. Chytridiomycosis is considered an emerging infectious disease linked to worldwide amphibian declines and extinctions. Although amphibians have well-developed immune defenses, clearance of this pathogen from the skin is often impaired. Previously, we showed that the adaptive immune system is involved in the control of the pathogen, but B. dendrobatidis releases factors that inhibit in vitro and in vivo lymphocyte responses and induce lymphocyte apoptosis. Little is known about the nature of the inhibitory factors released by this fungus. Here, we describe the isolation and characterization of three fungal metabolites produced by B. dendrobatidis but not by the closely related nonpathogenic chytrid Homolaphlyctis polyrhiza. These metabolites are methylthioadenosine (MTA), tryptophan, and an oxidized product of tryptophan, kynurenine (Kyn). Independently, both MTA and Kyn inhibit the survival and proliferation of amphibian lymphocytes and the Jurkat human T cell leukemia cell line. However, working together, they become effective at much lower concentrations. We hypothesize that B. dendrobatidis can adapt its metabolism to release products that alter the local environment in the skin to inhibit immunity and enhance the survival of the pathogen. 相似文献
180.